Related Experiment Videos
Immunophenotypic analysis with enhanced sensitivity of detection by enzymatic amplification staining
D Kaplan1, W Husel, H Meyerson
1Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA. drk5@po.cwpu.edu
Clinics in Laboratory Medicine
|January 5, 2002
Summary
Enzymatic amplification staining (EAS) enhances flow cytometry, enabling detection of low-abundance cell surface molecules. This new method improves diagnostic capabilities for analyzing blood cells, including malignant and reactive types.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Flow cytometry is a key diagnostic tool for single cell analysis.
- Conventional methods struggle to detect low-abundance cell surface molecules.
- Detecting low-expression molecules is crucial for understanding cell function.
Purpose of the Study:
- To introduce Enzymatic Amplification Staining (EAS) as a novel flow cytometry technique.
- To demonstrate EAS's ability to detect low-abundance cell surface molecules.
- To evaluate EAS's diagnostic value in patient blood cell analysis.
Main Methods:
- Development of Enzymatic Amplification Staining (EAS) technology.
- Utilizing enzymatically catalyzed deposition of reporter molecules for amplification.
- Applying EAS to flow cytometry for enhanced detection sensitivity.
Main Results:
- EAS successfully detects molecules expressed at low concentrations on cell surfaces.
- EAS resolves expression levels previously undetectable by standard methods.
- Demonstrated value in the diagnostic evaluation of patient samples.
Conclusions:
- EAS significantly improves the resolving power of flow cytometry.
- This technology is valuable for analyzing both malignant and reactive blood cells.
- EAS holds promise for advancing clinical diagnostics and cell analysis.